Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes.
about
Role of microRNA-146a in normal and malignant hematopoietic stem cell functionDeconstructing innate immune signaling in myelodysplastic syndromesMDS prognostic scoring systems – past, present, and futureDistinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancerOverexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrestThe KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapyTransfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.Digging deep into "dirty" drugs - modulation of the methylation machinery.miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signalingTranscriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome.Deregulation of microRNAs in myelodysplastic syndrome.Implication of microRNAs in the pathogenesis of MDS.Myelodysplastic syndrome hematopoietic stem cell.The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes.Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.MicroRNAs in myeloid malignancies.Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes.MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemiaMicroRNAs in Myeloid Hematological Malignancies.A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.The role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification.Stem and progenitor cell alterations in myelodysplastic syndromes.Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.MicroRNAs as prognostic biomarker and relapse indicator in leukemia.Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia.Circulating microRNA as Biomarkers in Hematological Malignancies.Differential expression of ribosomal proteins in myelodysplastic syndromes.IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes.
P2860
Q26864607-7D0E0ECE-8016-40D3-869C-2EF81AACECBFQ26991974-07DFDA9A-FFD3-4BB0-85CC-56BC79A22BF7Q28082460-9B1BFF6E-95FD-4959-A77C-6AF8368576DBQ31119968-4B0AB729-600C-4A99-80F7-B1EBDD20BC78Q35137424-B495A2B0-ABA5-47F4-8679-D66AF5E97C5BQ35254822-2357A8C6-025F-488D-A739-A696A706E5B0Q35785942-4A314480-8333-4D33-A5DE-AEA05F64E754Q36523796-F4053626-23F0-46FE-BBDE-95B054F1EF86Q36761526-4AA80FB4-47C5-4CA4-BDAC-662F91B3CC03Q36862388-5D5F36D1-CA57-48F2-8314-454E304856CFQ37011627-B695A094-FFA6-4AF4-A0E6-DE692087122EQ37919716-26906BA3-A0AC-4BB3-9C5F-EF3A11117DC3Q38008748-5B17B3CA-751E-4BCE-B127-EB609062910DQ38050694-31284530-DD71-43C6-B6EA-C79F959609FEQ38061848-EF00FB3E-AF7D-4462-8475-0743FB3771D1Q38074249-7995CFE4-FE15-4905-941C-5939E027E617Q38107272-BA7D3F7B-0EC2-4AA8-90F8-5B9AA23C252BQ38113961-91EB5878-7F69-4403-A775-7AD383411B8EQ38215614-C40E8A98-4A27-4BEA-855C-BBA61CECA1A1Q38599595-D8F7BCB0-F8BD-4DAA-9B90-A7D6E10727DCQ38637596-D9916EC5-CBFA-4D9E-A962-5583C8F88FEEQ38698438-84AA3546-DFFF-4B8D-9649-4DC42F67B43DQ38761791-1E5090FF-1BA3-450F-9184-688C3F48E564Q38880958-9A60125D-3307-49D9-9289-F4D4C64F47EDQ39167466-27A88A78-BA2E-401B-A9F5-2BB367FD1EB0Q46513684-573FB585-769B-438E-80B0-459E1770C565Q48693128-536FD714-F8C9-41B1-8CAD-06A8D967839FQ49521797-BCB94431-5027-4544-AE6C-7C8EBD35D324Q52803223-29666FD2-585E-40B7-B0DC-9BF1A8AA159EQ52900367-BC21B2EF-A06C-4ACA-9630-F6E655040E80Q52914167-C21B0BD8-6E0E-48AD-A8BC-1721AD49827EQ55361133-B5520E9B-8ADF-41E1-BDB1-1529BE8DD84C
P2860
Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of a risk depen ...... in myelodysplastic syndromes.
@ast
Identification of a risk depen ...... in myelodysplastic syndromes.
@en
Identification of a risk depen ...... in myelodysplastic syndromes.
@nl
type
label
Identification of a risk depen ...... in myelodysplastic syndromes.
@ast
Identification of a risk depen ...... in myelodysplastic syndromes.
@en
Identification of a risk depen ...... in myelodysplastic syndromes.
@nl
prefLabel
Identification of a risk depen ...... in myelodysplastic syndromes.
@ast
Identification of a risk depen ...... in myelodysplastic syndromes.
@en
Identification of a risk depen ...... in myelodysplastic syndromes.
@nl
P2093
P2860
P50
P1476
Identification of a risk depen ...... in myelodysplastic syndromes.
@en
P2093
Celia A Sigua
Chang-Gong Liu
Dung-Tsa Chen
Gerard J Nuovo
Gisela Caceres
Hans Alder
Justine A Clark
Kathy McGraw
Lubomir Sokol
Lynn Moscinski
P2860
P356
10.1111/J.1365-2141.2011.08581.X
P407
P577
2011-02-21T00:00:00Z